Interpreting Disclosures of Investment Securities Amgen Inc. reports the following disclosure relating to its accumulated other comprehensive income. Foreign Cash Available Currency Flow for-Sale Translation Hedges Securities Other $(794) $(9) $(216) $ - AOCI $(1,019) (14) (212) $ millions Balance as of December 31, 2017 Cumulative effect of change in accounting principle, net of tax Foreign currency translation adjustments Unrealized (losses) gains Reclassification adjustments to income Other Income taxes Balance as of December 31, 2018 92 393 (834) 548 (14) (212) (742) 941 (3) (3) (105) $(3) $(1,154) (114) $362 9 $(507) $(1,006) a. Amgen reports unrealized gains and losses on available-for-sale securities as part of AOCI. Which of the following types of investments could be included in this account? Select all that apply. Investments with Unrealized Gains (Losses) in AOCI i. Bonds issued by US corporations. ii. Common stock traded on US stock exchange. iii. Common stock traded on foreign stock exchange. iv. Debt securities issued by a foreign government. v. Municipal bonds. vi. U.S. Treasury bills. b. Consider the securities held in the available-for-sale portfolio at December 31, 2018. Identify each of the following statements as true or false. i. At December 31, 2018, the fair value of the securities was $507 million less than their amortized cost. ii. At December 31, 2018, the fair value of the securities was $507 million greater than their amortized cost. iii. At December 31, 2018, the fair value of the securities was $507 million lower than their value at December 31, 2017. C iv. At December 31, 2018, the fair value of the securities was $291 million lower than their value at December 31, 2017. C. Consider the securities held in the available-for-sale portfolio at December 31, 2018. Identify each of the following statements as true or false in describing the change in the market value of those securities during the year. i. Decreased by $507 million. ii. Decreased by $834 million. iii. Increased by $834 million. iv. Decreased by $287 million. d. Amgen increased AOCI by $548 million for reclassification adjustments to income. Identify each of the following statements as true or false in describing what this line item means. i. During 2018, Amgen sold available-for-sale securities and realized a loss of $548 million. ii. During 2018, Amgen sold available-for-sale securities and realized a gain of $548 million. iii. During 2018, Amgen sold available-for-sale securities that had unrealized gains of $548 million at December 31, 2017. iv. During 2018, Amgen sold available-for-sale securities that had unrealized losses of $548 million at December 31, 2017